These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 854465

  • 1. [Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
    Mazurowa A, Krykowski E, Pluzańska A, Dmochowska M, Robak T, Polkowska-Kulesza E, Skorek TO, Fajndt S, Boguszewska E.
    Pol Tyg Lek; 1977 Apr 04; 32(14):521-3. PubMed ID: 854465
    [No Abstract] [Full Text] [Related]

  • 2. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May 04; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 3. Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Diehl LF, Perry DJ, Terebelo H, Baldwin PE, Hurwitz M, Kimball DB, Dorn RV.
    Cancer Treat Rep; 1983 Sep 04; 67(9):827-9. PubMed ID: 6883360
    [Abstract] [Full Text] [Related]

  • 4. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M, Lauria F, Mazza P, Cantore M, Gherlinzoni F, Tura S.
    Haematologica; 1985 Sep 04; 70(2):148-54. PubMed ID: 3924778
    [No Abstract] [Full Text] [Related]

  • 5. Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
    Weiner MJ, Sicular A, Blaugrund SM, Sattler SM.
    N Y State J Med; 1981 Sep 04; 81(10):1509-11. PubMed ID: 6944619
    [No Abstract] [Full Text] [Related]

  • 6. [Hodgkin's lymphoma in children: results of treatment with the MOPP protocol and a combination of radiotherapy and chemotherapy].
    Vuković I, Janković MB, Janić D, Stojimirović E.
    Srp Arh Celok Lek; 1985 Sep 04; 113(11-12):1013-21. PubMed ID: 3841764
    [No Abstract] [Full Text] [Related]

  • 7. [CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    Sampi K, Honda T, Hattori M.
    Rinsho Ketsueki; 1984 Feb 04; 25(2):164-8. PubMed ID: 6547984
    [No Abstract] [Full Text] [Related]

  • 8. Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Canellos GP.
    Semin Oncol; 1990 Feb 04; 17(1 Suppl 2):2-6. PubMed ID: 1689509
    [Abstract] [Full Text] [Related]

  • 9. [MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Frau A, Montalar J.
    Med Clin (Barc); 1985 May 18; 84(19):801. PubMed ID: 3839875
    [No Abstract] [Full Text] [Related]

  • 10. The role of dose and rate of administration of MOPP drugs in 97 retrospective Hodgkin's patients.
    Gobbi PG, Cavalli C, Rossi A, Bertoloni D, Galeone F, Pieresca C, Grignani E.
    Haematologica; 1987 May 18; 72(6):523-8. PubMed ID: 3126109
    [No Abstract] [Full Text] [Related]

  • 11. [Multiple drug treatment of Hodgkin's disease: the MOPP schedule].
    Singer Z, Dzieza-Lalowicz I, Kardaszewicz S, Rozek-Lesiak K.
    Nowotwory; 1978 May 18; 28(2):203-8. PubMed ID: 683884
    [No Abstract] [Full Text] [Related]

  • 12. Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Bonadonna G, Santoro A, Bonfante V, Valagussa P.
    Cancer Treat Rep; 1982 Apr 18; 66(4):881-7. PubMed ID: 6176323
    [Abstract] [Full Text] [Related]

  • 13. Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D.
    J Chemother; 1989 Jul 18; 1(4 Suppl):1254-6. PubMed ID: 16312855
    [No Abstract] [Full Text] [Related]

  • 14. [Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Kozai Y, Ohyama T, Kodo H, Tomori G.
    Gan To Kagaku Ryoho; 1992 Dec 18; 19(14):2407-9. PubMed ID: 1281397
    [Abstract] [Full Text] [Related]

  • 15. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 18; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 16. Randomized study for the treatment of advanced Hodgkin's disease: MOPP vs. LOPP.
    Avilés A, Díaz-Maqueo JC, García EL, Torras V, López-Vancell D.
    Arch Invest Med (Mex); 1991 Sep 18; 22(1):45-50. PubMed ID: 1819976
    [Abstract] [Full Text] [Related]

  • 17. Skin infiltration in Hodgkin's disease.
    Gordon RA, Lookingbill DP, Abt AB.
    Arch Dermatol; 1980 Sep 18; 116(9):1038-40. PubMed ID: 7416756
    [Abstract] [Full Text] [Related]

  • 18. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA, Sarma SK, Ahmed Q.
    Bangladesh Med Res Counc Bull; 1982 Dec 18; 8(2):63-7. PubMed ID: 6897860
    [Abstract] [Full Text] [Related]

  • 19. Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    McElwain TJ, Wrigley PF, Hunter A, Crowther D, Malpas JS, Peckham MJ, Smithers DW, Fairley GH.
    Natl Cancer Inst Monogr; 1973 May 18; 36():395-402. PubMed ID: 4744597
    [No Abstract] [Full Text] [Related]

  • 20. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Aghai E, Kende G, Many A, Ramot B.
    Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.